Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials

BACKGROUND: Prediction models for venous thromboembolism recurrence will likely be improved by adding levels of coagulation factors. Risk assessment is ideally performed during anticoagulant treatment, however, the influence of direct oral anticoagulants on coagulation factors is uncertain. OBJECTIV...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Res Pract Thromb Haemost
Prif Awduron: Scheres, Luuk J. J., Lijfering, Willem M., Middeldorp, Saskia, Cheung, Yuk W., Barco, Stefano, Cannegieter, Suzanne C., Coppens, Michiel
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2018
Pynciau:
Original Articles: Thrombosis
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178718/
https://ncbi.nlm.nih.gov/pubmed/30349888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12142
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg